Synflorix - direct healthcare professional communication (DHPC)

Pneumococcal polysaccharide serotype 23F / Pneumococcal polysaccharide serotype 4 / Pneumococcal polysaccharide serotype 5 / Pneumococcal polysaccharide serotype 6B / Pneumococcal polysaccharide serotype 7F / Pneumococcal polysaccharide serotype 9V / Pneumococcal polysaccharide serotype 1 / Pneumococcal polysaccharide serotype 14 / Pneumococcal polysaccharide serotype 18C / Pneumococcal polysaccharide serotype 19F

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Synflorix: packaging issue potentially impacting the sterility of needle softpacks of Synflorix

Key facts

• Medicine name:
  Synflorix
• Active substance:
  • Pneumococcal polysaccharide serotype 23F
  • Pneumococcal polysaccharide serotype 4
  • Pneumococcal polysaccharide serotype 5
  • Pneumococcal polysaccharide serotype 6B
  • Pneumococcal polysaccharide serotype 7F
  • Pneumococcal polysaccharide serotype 9V
  • Pneumococcal polysaccharide serotype 1
  • Pneumococcal polysaccharide serotype 14
  • Pneumococcal polysaccharide serotype 18C
  • Pneumococcal polysaccharide serotype 19F
• Therapeutic area (MeSH):
  • Pneumococcal Infections
  • Immunization
• DHPC type:
  Quality defect
• Human ATC codes:
  J07AL52
• Dissemination date:
  10/10/2024